Elekta

Elekta is a global leader in precision radiation medicine, with a mission to improve, prolong, and save patient lives through innovative cancer care solutions. Founded on the breakthrough Leksell Gamma Knife®, the company has evolved into a comprehensive oncology technology provider, with its flagship Elekta Unity MR-Linac representing a paradigm shift towards real-time adaptive radiotherapy. Its strategy focuses on integrating advanced hardware, intelligent software, and data-driven insights to establish adaptive workflows as the clinical standard, supported by a recurring revenue model from equipment sales, service, and software. Elekta maintains a significant global footprint, serving thousands of hospitals and continuously expanding its portfolio to address a broad range of cancer types.

An integrated ecosystem of precision radiation hardware (MR-Linac, Gamma Knife, Linacs), intelligent treatment planning and oncology information software, and AI-powered analytics designed to enable real-time adaptive radiotherapy and streamline clinical workflows.

Elekta operates in a global duopoly primarily with Varian (Siemens Healthineers), the market leader in linear accelerators. Its key advantages are leadership in MR-guided radiotherapy (Unity) and the gold-standard Leksell Gamma Knife. The competitive battleground centers on next-generation adaptive therapy platforms, AI software, and oncology information systems.